Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

15.39
-0.6200-3.87%
Post-market: 15.400.0100+0.06%17:57 EDT
Volume:1.28M
Turnover:20.13M
Market Cap:765.84M
PE:-4.17
High:16.23
Open:15.90
Low:15.30
Close:16.01
Loading ...

Here's Why We're Not Too Worried About KalVista Pharmaceuticals' (NASDAQ:KALV) Cash Burn Situation

Simply Wall St.
·
09 Jul

KalVista price target lowered to $27 from $30 at H.C. Wainwright

TIPRANKS
·
08 Jul

KalVista price target raised to $37 from $22 at BofA

TIPRANKS
·
08 Jul

Kalvista Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $27 From $20

THOMSON REUTERS
·
08 Jul

FDA Approves KalVista Pharmaceuticals' Ekterly as First Oral On-Demand Therapy for Hereditary Angioedema; DRI Healthcare Trust Increases Investment to $127 Million

Reuters
·
08 Jul

KalVista Pharmaceuticals Is Maintained at Outperform by Leerink Partners

Dow Jones
·
08 Jul

Bank of America Securities Keeps Their Buy Rating on KalVista Pharmaceuticals (KALV)

TIPRANKS
·
08 Jul

Kalvista Pharmaceuticals Inc expected to post a loss of 86 cents a share - Earnings Preview

Reuters
·
08 Jul

Jefferies Raises KalVista Pharmaceuticals' Price Target to $40 From $32, Buy Rating Maintained

MT Newswires Live
·
08 Jul

KalVista price target raised to $40 from $32 at Jefferies

TIPRANKS
·
08 Jul

Stifel Nicolaus Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)

TIPRANKS
·
08 Jul

BUZZ-U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRock

Reuters
·
08 Jul

KalVista Pharmaceuticals Up Over 17%, on Pace for Largest Percent Increase Since September 2024 -- Data Talk

Dow Jones
·
07 Jul

Kalvista Pharmaceuticals Shares Jump 19.5% After FDA Approves Co's Swelling Disorder Drug

THOMSON REUTERS
·
07 Jul

Sector Update: Health Care Stocks Lean Lower Premarket Monday

MT Newswires Live
·
07 Jul

Kalvista Pharmaceuticals Exec Says Anticipate Ekterly Availability Mid July

THOMSON REUTERS
·
07 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Constellation Brands, KalVista Pharma

Reuters
·
07 Jul

Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV) and Hims & Hers Health (HIMS)

TIPRANKS
·
07 Jul

Kalvista Pharmaceuticals Shares Jump 16% Premarket After FDA Approves Co's Swelling Disorder Drug

THOMSON REUTERS
·
07 Jul

KalVista announces FDA approval for EKTERLY

TIPRANKS
·
07 Jul